Cargando…
T cell co-stimulator inducible co-stimulatory (ICOS) exerts potential anti-atherosclerotic roles through downregulation of vascular smooth muscle phagocytosis and proliferation
BACKGROUND: Atherosclerosis (AS) is a chronic inflammatory disease. The role of the immune system in the etiology of the disease, particularly T cells, has been widely studied and is well established. T cell activation directly regulates co-signaling molecules present in immune synapses. Targeting o...
Autores principales: | Zhong, Zhixiong, Zhang, Qunji, Tan, Linkai, Guo, Xuemin, Gan, Caiyan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7791234/ https://www.ncbi.nlm.nih.gov/pubmed/33437796 http://dx.doi.org/10.21037/atm-20-7342 |
Ejemplares similares
-
T cell Co-Stimulatory molecules ICOS and CD28 stratify idiopathic pulmonary fibrosis survival
por: Bonham, Catherine A., et al.
Publicado: (2019) -
Inducible co-stimulator inhibits lipid phagocytosis of human aortic smooth muscle cells by down-regulating CD36 expression
por: Liang, Meng, et al.
Publicado: (2022) -
Inducible co-stimulatory molecule (ICOS) alleviates paclitaxel-induced neuropathic pain via an IL-10-mediated mechanism in female mice
por: Sankaranarayanan, Ishwarya, et al.
Publicado: (2023) -
ICOS Co-Stimulation: Friend or Foe?
por: Wikenheiser, Daniel J., et al.
Publicado: (2016) -
Roles of Vascular Smooth Muscle Cells in Atherosclerotic Calcification
por: Woo, Sang-Ho, et al.
Publicado: (2023)